UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA approves first drug for tardive dyskinesia
The U.S. Food and Drug Administration (FDA) said Tuesday it approved Ingrez...
by Constance Williams
|
2017-04-12 16:11
라인
KPAC 2017 focuses on ‘open innovation’ by pharma industry
Korean and foreign pharmaceutical companies got together at the Korea Pharm...
by Marian Chu
|
2017-04-11 18:52
라인
FDA rejects Merck’s bid to expand Januvia label
Merck & Co. said the U.S. FDA had rejected its additional non-disclosure ag...
by Constance Williams
|
2017-04-11 11:39
라인
Hanmi makes public 23 new drug pipelines on its website
Hanmi Pharm한미약품 (CEO Kwon Se-Chang권세창 and Woo Jong-soo우종수), announced 23 ne...
by Marian Chu
|
2017-04-10 18:04
라인
K-Pharma Academy promotes Korean-Latin American ties
The Korea Health Industry Development Institute (KHIDI) completed its annua...
by Constance Williams
|
2017-04-10 15:40
라인
Hanmi’s osteoporosis therapy combines Evista with vitamin D
Hanmi Pharm has released a complex drug by combining Evista (compound: Ralo...
by Lee Hye-seon
|
2017-04-10 11:59
라인
Daewoong releases generic of cognition-enhancing Gliatilin for export
Daewoong Pharm, which handed over the domestic selling right of Gliatilin, ...
by Lee Hye-seon
|
2017-04-07 14:53
라인
Lilly’s new drug marks progress for treating soft tissue sarcoma
Last year, the U.S. and European food and drug agencies granted approval to...
by Marian Chu
|
2017-04-06 10:56
라인
LG Chem 'targets sales of $2.2-bil. in life science by 2025'
LG Chem plans to invest 1 trillion won ($890 million) into research and dev...
by Lee Hye-seon
|
2017-04-05 17:04
라인
FDA approves drug to treat Huntington’s chorea
The U.S. Food and Drug Administration approved Austedo™(deutetrabenaz...
by Constance Williams
|
2017-04-05 10:39
라인
Sanofi's Japanese encephalitis vaccine ad fuels fear
Pharmaceutical company Sanofi has come under fire for allegedly marketing i...
by Nam Doo-hyun
|
2017-04-04 17:30
라인
Which is better; multinational or global?
Korea Research-based Pharmaceutical Industry Association (KRPIA), a group o...
by Marian Chu
|
2017-04-03 18:49
라인
CJ HealthCare returns to single CEO system
CJ HealthCare has shifted back to the single CEO system led by Kang Seok-he...
by Lee Hye-seon
|
2017-04-03 18:13
라인
Regulators suspend ads for oral contraceptive for 1 month
Dong-A Pharm will not be able to release ad about an oral contraceptive Myv...
by Lee Hye-seon
|
2017-04-03 16:41
라인
US FDA approves new drug for multiple sclerosis
The U.S. Food and Drug Administration Tuesday approved Ocrevus (ocrelizumab...
by Constance Williams
|
2017-03-30 14:18
라인
Antidiabetic drug released for patients with kidney problem
MSD Korea, the Korean branch of Merck & Co, released Wednesday a new 25mg d...
by Marian Chu
|
2017-03-29 16:38
라인
'Marketing strategies should differ between advanced, emerging markets'
Korea’s pharmaceutical companies should differentiate their strategies in e...
by Lee Hye-seon
|
2017-03-29 16:04
라인
Roche Diagnostics Korea to prosper with Korean market
It’s been some time that low birthrate became one of the most serious socia...
by Constance Williams
|
2017-03-29 14:31
라인
Sanofi, Regeneron win FDA approval for new eczema injection
The U.S. Food and Drug Administration Wednesday approved Dupixent, a new, p...
by Marian Chu
|
2017-03-29 14:20
라인
What's in a name?
Interests in bio industry here are hotter now than ever before. Not just th...
by Song Soo-youn
|
2017-03-28 13:47
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top